News & Press Releases

The 2024 ISPE Aseptic Conference will take place 12-13 March 2024 in Vienna, Austria, and virtually. ISPE has announced representative participation from health authorities around the world at the 2024 ISPE Aseptic Conference . Featured spea kers...

Industry experts have shared insights on 2024 predictions for the pharmaceutical industry with Pharma Manufacturing. In part two of this series, ISPE President and CEO Thomas Hartman highlights that accountability and authenticity will be key...

ISPE President and CEO Thomas Hartman provides insights on how AI may impact the biotech industry in 2024. Thomas observes that the meteoric rise of AI took every industry by surprise in 2023. In 2024, he notes, “companies will have more time to take...

ISPE President and CEO Thomas Hartman calls attention to the importance of addressing drug shortages in 2024 in part three of an article, “Scrip Asks…What Does 2024 Hold for Biopharma?” The article features expert insights on manufacturing and supply...

In an interview with Bioprocess Online, Ben Stevens, Director of CMC Policy and Advocacy at GSK and member of the International Society for Pharmaceutical Engineering (ISPE), provides guidance and insights on the state of change management protocols...

Thomas Hartman, President and CEO of ISPE, has been featured in a recent podcast episode with Life Science Success. He and the host, Don Davis, discuss Hartman’s career journey and the impact ISPE is having on the industry. Hartman touches on...

Experts have weighed in with their perspectives on anticipated challenges and opportunities anticipated for the pharmaceutical industry in 2024, in an article published by Pharmaceutical Technology. Thomas Hartman, President and CEO with ISPE...

Thomas Hartman, President and CEO of the International Society for Pharmaceutical Engineering, is among several key industry leaders featured in this article, discussing the advantages and challenges associated with integrating AI into drug...

The COVID-19 pandemic has prompted regulators and the industry to consider how best to prepare for future emergencies. In June 2023, the European Commission finalized deals with various European pharmaceutical companies to reserve manufacturing...

The ISPE Foundation, with support from like-minded organizations such as Gilead Sciences, champions programs that create opportunity, diversity, and success within the global pharmaceutical industry. ISPE, in partnership with the ISPE Foundation and...